Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–10 of 10 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT00942331
- Conditions
- Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +32 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Providence Hospital Mobile, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
NCT03513952
- Conditions
- Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Carcinoma, +40 more
- Locations
-
- Kaiser Permanente-Riverside Riverside, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Straub Clinic and Hospital Honolulu, Hawaii, United States
- University of Hawaii Cancer Center Honolulu, Hawaii, United States
Active, Not Recruiting
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
NCT05092958
- Conditions
- Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, +30 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Sutter Auburn Faith Hospital Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
- Palo Alto Medical Foundation-Fremont Fremont, California, United States
Active, Not Recruiting
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
NCT03237780
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Locally Advanced Bladder Urothelial Carcinoma, +36 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Keck Medicine of USC Buena Park Buena Park, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
Active, Not Recruiting
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy
NCT04963153
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +36 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- Moffitt Cancer Center Tampa, Florida, United States
Active, Not Recruiting
ARID1A and/or KDM6A Mutation and CXCL13 Expression
NCT04953104
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +48 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy
NCT04637594
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Locally Advanced Bladder Urothelial Carcinoma, +12 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Active, Not Recruiting
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
NCT04940299
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +72 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma
NCT04848519
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +30 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
Active, Not Recruiting
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
NCT03582475
- Conditions
- Bladder Small Cell Neuroendocrine Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +36 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States